• Academy
    • Webinars on-demand
    • Online courses
    • 89th EAS Congress, Helsinki 2021
  • Publications
  • Become an EAS member
    Sign in
    • Academy
      • Webinars on-demand
      • Online courses
      • 89th EAS Congress, Helsinki 2021
    • Publications
    • Become an EAS member
    • Sign in

    Origin/Event: 88th EAS Congress 2020

    Why and in whom is combination needed?

    When do we need add on therapies to statin?

    What is the landscape on lipid management today?

    What is the environment doing to cardiovascular health?

    What do we know so far about bempedoic acid?

    Translating science into guidance on the prevention of cardiovascular disease

    The value of omega 3 – from biology to clinical practice

    The lipoprotein(a) story – from risk factor to causality to clinical trials

    The biology of PCSK9

    The Angiopoietin-like proteins, controlling lipoprotein metabolism

    Load More

    Recent Posts

    • ASCVD and Lp(a) assessment survey among clinicians
    • EAS Annual Members’ General Assembly
    • Gene-based therapies. The next generation of Atherosclerosis treatment
    • EAS Lipid Clinic Network

    Recent Comments

      © 2022 - EAS Digital

      Report

      Contains abusive or derogatory content
      Contains mature or sensitive content
      Contains misleading or false information
      Contains spam, fake content or potential malware
      Harassment or bullying behavior

      Block Member?

      Please confirm you want to block this member.

      You will no longer be able to:

      • See blocked member's posts
      • Mention this member in posts
      • Invite this member to groups
      • Message this member
      • Add this member as a connection

      Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

      Report

      You have already reported this